Serveur sur les données et bibliothèques médicales au Maghreb (version finale)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Identification of novel nt-MGAM inhibitors for potential treatment of type 2 diabetes: Virtual screening, atom based 3D-QSAR model, docking analysis and ADME study.

Identifieur interne : 000426 ( Main/Exploration ); précédent : 000425; suivant : 000427

Identification of novel nt-MGAM inhibitors for potential treatment of type 2 diabetes: Virtual screening, atom based 3D-QSAR model, docking analysis and ADME study.

Auteurs : Aicha Laoud [Algérie] ; Fouad Ferkous [Algérie] ; Laura Maccari [Italie] ; Giorgio Maccari [Italie] ; Youcef Saihi [Algérie] ; Khaireddine Kraim [Algérie]

Source :

RBID : pubmed:29274684

Descripteurs français

English descriptors

Abstract

In this study, a virtual screening procedure was applied to identify new potential nt-MGAM inhibitors as a possible medication for type 2 diabetes. To this aim, a series of salacinol analogues were first investigated by docking analysis for their binding to the X-ray structure of the biological target nt-MGAM. Key interactions for ligand binding into the receptor active site were identified which shared common features to those found for other known inhibitors, which strengthen the results of this study. 3D QSAR model was then built and showed to be statistically significant and with a good predictive power for the training (R2 = 0.99, SD = 0.17, F = 555.3 and N = 27) and test set (Q2 = 0.81, Pearson(r) = 0.92, RMSE = 0.52, N = 08). The model was then used to virtually screen the ZINC database with the aim of identifying novel chemical scaffolds as potential nt-MGAM inhibitors. Further, in silico predicted ADME properties were investigated for the most promising molecules. The outcome of this investigation sheds light on the molecular characteristics of the binding of salacinol analogues to nt-MGAM enzyme and identifies new possible inhibitors which have the potential to be developed into drugs, thus significantly contributing to the design and optimization of therapeutic strategies against type 2 diabetes.

DOI: 10.1016/j.compbiolchem.2017.12.003
PubMed: 29274684


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Identification of novel nt-MGAM inhibitors for potential treatment of type 2 diabetes: Virtual screening, atom based 3D-QSAR model, docking analysis and ADME study.</title>
<author>
<name sortKey="Laoud, Aicha" sort="Laoud, Aicha" uniqKey="Laoud A" first="Aicha" last="Laoud">Aicha Laoud</name>
<affiliation wicri:level="1">
<nlm:affiliation>LCOA: Laboratoire de Chimie Organique Appliquée, Département de Chimie, Faculté des Sciences, Université Badji-Mokhtar - Annaba, BP 12, Annaba, Algeria.</nlm:affiliation>
<country xml:lang="fr">Algérie</country>
<wicri:regionArea>LCOA: Laboratoire de Chimie Organique Appliquée, Département de Chimie, Faculté des Sciences, Université Badji-Mokhtar - Annaba, BP 12, Annaba</wicri:regionArea>
<wicri:noRegion>Annaba</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ferkous, Fouad" sort="Ferkous, Fouad" uniqKey="Ferkous F" first="Fouad" last="Ferkous">Fouad Ferkous</name>
<affiliation wicri:level="1">
<nlm:affiliation>LCOA: Laboratoire de Chimie Organique Appliquée, Département de Chimie, Faculté des Sciences, Université Badji-Mokhtar - Annaba, BP 12, Annaba, Algeria.</nlm:affiliation>
<country xml:lang="fr">Algérie</country>
<wicri:regionArea>LCOA: Laboratoire de Chimie Organique Appliquée, Département de Chimie, Faculté des Sciences, Université Badji-Mokhtar - Annaba, BP 12, Annaba</wicri:regionArea>
<wicri:noRegion>Annaba</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Maccari, Laura" sort="Maccari, Laura" uniqKey="Maccari L" first="Laura" last="Maccari">Laura Maccari</name>
<affiliation wicri:level="1">
<nlm:affiliation>Lead Discovery Siena s.r.l, Via Vittorio Alfieri 31, I-53019, Castelnuovo Berardenga, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Lead Discovery Siena s.r.l, Via Vittorio Alfieri 31, I-53019, Castelnuovo Berardenga</wicri:regionArea>
<wicri:noRegion>Castelnuovo Berardenga</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Maccari, Giorgio" sort="Maccari, Giorgio" uniqKey="Maccari G" first="Giorgio" last="Maccari">Giorgio Maccari</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biotechnology, Chemistry and Pharmacy, University of Siena, I-53100, Siena, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Biotechnology, Chemistry and Pharmacy, University of Siena, I-53100, Siena</wicri:regionArea>
<wicri:noRegion>Siena</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Saihi, Youcef" sort="Saihi, Youcef" uniqKey="Saihi Y" first="Youcef" last="Saihi">Youcef Saihi</name>
<affiliation wicri:level="1">
<nlm:affiliation>LCOA: Laboratoire de Chimie Organique Appliquée, Département de Chimie, Faculté des Sciences, Université Badji-Mokhtar - Annaba, BP 12, Annaba, Algeria.</nlm:affiliation>
<country xml:lang="fr">Algérie</country>
<wicri:regionArea>LCOA: Laboratoire de Chimie Organique Appliquée, Département de Chimie, Faculté des Sciences, Université Badji-Mokhtar - Annaba, BP 12, Annaba</wicri:regionArea>
<wicri:noRegion>Annaba</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kraim, Khaireddine" sort="Kraim, Khaireddine" uniqKey="Kraim K" first="Khaireddine" last="Kraim">Khaireddine Kraim</name>
<affiliation wicri:level="1">
<nlm:affiliation>LCOA: Laboratoire de Chimie Organique Appliquée, Département de Chimie, Faculté des Sciences, Université Badji-Mokhtar - Annaba, BP 12, Annaba, Algeria; ENSET: Ecole Normale Supérieure d'Enseignement Technologique, Azzaba, Skikda, Algeria. Electronic address: kkhchem@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Algérie</country>
<wicri:regionArea>LCOA: Laboratoire de Chimie Organique Appliquée, Département de Chimie, Faculté des Sciences, Université Badji-Mokhtar - Annaba, BP 12, Annaba, Algeria; ENSET: Ecole Normale Supérieure d'Enseignement Technologique, Azzaba, Skikda</wicri:regionArea>
<wicri:noRegion>Skikda</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29274684</idno>
<idno type="pmid">29274684</idno>
<idno type="doi">10.1016/j.compbiolchem.2017.12.003</idno>
<idno type="wicri:Area/PubMed/Corpus">000387</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000387</idno>
<idno type="wicri:Area/PubMed/Curation">000386</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000386</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000345</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000345</idno>
<idno type="wicri:Area/Main/Merge">000426</idno>
<idno type="wicri:Area/Main/Curation">000426</idno>
<idno type="wicri:Area/Main/Exploration">000426</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Identification of novel nt-MGAM inhibitors for potential treatment of type 2 diabetes: Virtual screening, atom based 3D-QSAR model, docking analysis and ADME study.</title>
<author>
<name sortKey="Laoud, Aicha" sort="Laoud, Aicha" uniqKey="Laoud A" first="Aicha" last="Laoud">Aicha Laoud</name>
<affiliation wicri:level="1">
<nlm:affiliation>LCOA: Laboratoire de Chimie Organique Appliquée, Département de Chimie, Faculté des Sciences, Université Badji-Mokhtar - Annaba, BP 12, Annaba, Algeria.</nlm:affiliation>
<country xml:lang="fr">Algérie</country>
<wicri:regionArea>LCOA: Laboratoire de Chimie Organique Appliquée, Département de Chimie, Faculté des Sciences, Université Badji-Mokhtar - Annaba, BP 12, Annaba</wicri:regionArea>
<wicri:noRegion>Annaba</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ferkous, Fouad" sort="Ferkous, Fouad" uniqKey="Ferkous F" first="Fouad" last="Ferkous">Fouad Ferkous</name>
<affiliation wicri:level="1">
<nlm:affiliation>LCOA: Laboratoire de Chimie Organique Appliquée, Département de Chimie, Faculté des Sciences, Université Badji-Mokhtar - Annaba, BP 12, Annaba, Algeria.</nlm:affiliation>
<country xml:lang="fr">Algérie</country>
<wicri:regionArea>LCOA: Laboratoire de Chimie Organique Appliquée, Département de Chimie, Faculté des Sciences, Université Badji-Mokhtar - Annaba, BP 12, Annaba</wicri:regionArea>
<wicri:noRegion>Annaba</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Maccari, Laura" sort="Maccari, Laura" uniqKey="Maccari L" first="Laura" last="Maccari">Laura Maccari</name>
<affiliation wicri:level="1">
<nlm:affiliation>Lead Discovery Siena s.r.l, Via Vittorio Alfieri 31, I-53019, Castelnuovo Berardenga, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Lead Discovery Siena s.r.l, Via Vittorio Alfieri 31, I-53019, Castelnuovo Berardenga</wicri:regionArea>
<wicri:noRegion>Castelnuovo Berardenga</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Maccari, Giorgio" sort="Maccari, Giorgio" uniqKey="Maccari G" first="Giorgio" last="Maccari">Giorgio Maccari</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biotechnology, Chemistry and Pharmacy, University of Siena, I-53100, Siena, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Biotechnology, Chemistry and Pharmacy, University of Siena, I-53100, Siena</wicri:regionArea>
<wicri:noRegion>Siena</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Saihi, Youcef" sort="Saihi, Youcef" uniqKey="Saihi Y" first="Youcef" last="Saihi">Youcef Saihi</name>
<affiliation wicri:level="1">
<nlm:affiliation>LCOA: Laboratoire de Chimie Organique Appliquée, Département de Chimie, Faculté des Sciences, Université Badji-Mokhtar - Annaba, BP 12, Annaba, Algeria.</nlm:affiliation>
<country xml:lang="fr">Algérie</country>
<wicri:regionArea>LCOA: Laboratoire de Chimie Organique Appliquée, Département de Chimie, Faculté des Sciences, Université Badji-Mokhtar - Annaba, BP 12, Annaba</wicri:regionArea>
<wicri:noRegion>Annaba</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kraim, Khaireddine" sort="Kraim, Khaireddine" uniqKey="Kraim K" first="Khaireddine" last="Kraim">Khaireddine Kraim</name>
<affiliation wicri:level="1">
<nlm:affiliation>LCOA: Laboratoire de Chimie Organique Appliquée, Département de Chimie, Faculté des Sciences, Université Badji-Mokhtar - Annaba, BP 12, Annaba, Algeria; ENSET: Ecole Normale Supérieure d'Enseignement Technologique, Azzaba, Skikda, Algeria. Electronic address: kkhchem@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Algérie</country>
<wicri:regionArea>LCOA: Laboratoire de Chimie Organique Appliquée, Département de Chimie, Faculté des Sciences, Université Badji-Mokhtar - Annaba, BP 12, Annaba, Algeria; ENSET: Ecole Normale Supérieure d'Enseignement Technologique, Azzaba, Skikda</wicri:regionArea>
<wicri:noRegion>Skikda</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Computational biology and chemistry</title>
<idno type="eISSN">1476-928X</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Diabetes Mellitus, Type 2 (drug therapy)</term>
<term>Drug Evaluation, Preclinical (MeSH)</term>
<term>Glycoside Hydrolase Inhibitors (chemistry)</term>
<term>Hydrogen Bonding (MeSH)</term>
<term>Hypoglycemic Agents (chemistry)</term>
<term>Ligands (MeSH)</term>
<term>Molecular Docking Simulation (MeSH)</term>
<term>Quantitative Structure-Activity Relationship (MeSH)</term>
<term>Sugar Alcohols (chemistry)</term>
<term>Sulfuric Acid Esters (chemistry)</term>
<term>alpha-Glucosidases (chemistry)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Diabète de type 2 (traitement médicamenteux)</term>
<term>Hypoglycémiants (composition chimique)</term>
<term>Inhibiteurs des glycoside hydrolases (composition chimique)</term>
<term>Liaison hydrogène (MeSH)</term>
<term>Ligands (MeSH)</term>
<term>Polyols (composition chimique)</term>
<term>Relation quantitative structure-activité (MeSH)</term>
<term>Simulation de docking moléculaire (MeSH)</term>
<term>Sulfates organiques (composition chimique)</term>
<term>alpha-Glucosidase (composition chimique)</term>
<term>Évaluation préclinique de médicament (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Glycoside Hydrolase Inhibitors</term>
<term>Hypoglycemic Agents</term>
<term>Sugar Alcohols</term>
<term>Sulfuric Acid Esters</term>
<term>alpha-Glucosidases</term>
</keywords>
<keywords scheme="MESH" qualifier="composition chimique" xml:lang="fr">
<term>Hypoglycémiants</term>
<term>Inhibiteurs des glycoside hydrolases</term>
<term>Polyols</term>
<term>Sulfates organiques</term>
<term>alpha-Glucosidase</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Diabetes Mellitus, Type 2</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Diabète de type 2</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Drug Evaluation, Preclinical</term>
<term>Hydrogen Bonding</term>
<term>Ligands</term>
<term>Molecular Docking Simulation</term>
<term>Quantitative Structure-Activity Relationship</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Liaison hydrogène</term>
<term>Ligands</term>
<term>Relation quantitative structure-activité</term>
<term>Simulation de docking moléculaire</term>
<term>Évaluation préclinique de médicament</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In this study, a virtual screening procedure was applied to identify new potential nt-MGAM inhibitors as a possible medication for type 2 diabetes. To this aim, a series of salacinol analogues were first investigated by docking analysis for their binding to the X-ray structure of the biological target nt-MGAM. Key interactions for ligand binding into the receptor active site were identified which shared common features to those found for other known inhibitors, which strengthen the results of this study. 3D QSAR model was then built and showed to be statistically significant and with a good predictive power for the training (R
<sup>2</sup>
 = 0.99, SD = 0.17, F = 555.3 and N = 27) and test set (Q
<sup>2</sup>
 = 0.81, Pearson(r) = 0.92, RMSE = 0.52, N = 08). The model was then used to virtually screen the ZINC database with the aim of identifying novel chemical scaffolds as potential nt-MGAM inhibitors. Further, in silico predicted ADME properties were investigated for the most promising molecules. The outcome of this investigation sheds light on the molecular characteristics of the binding of salacinol analogues to nt-MGAM enzyme and identifies new possible inhibitors which have the potential to be developed into drugs, thus significantly contributing to the design and optimization of therapeutic strategies against type 2 diabetes.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Algérie</li>
<li>Italie</li>
</country>
</list>
<tree>
<country name="Algérie">
<noRegion>
<name sortKey="Laoud, Aicha" sort="Laoud, Aicha" uniqKey="Laoud A" first="Aicha" last="Laoud">Aicha Laoud</name>
</noRegion>
<name sortKey="Ferkous, Fouad" sort="Ferkous, Fouad" uniqKey="Ferkous F" first="Fouad" last="Ferkous">Fouad Ferkous</name>
<name sortKey="Kraim, Khaireddine" sort="Kraim, Khaireddine" uniqKey="Kraim K" first="Khaireddine" last="Kraim">Khaireddine Kraim</name>
<name sortKey="Saihi, Youcef" sort="Saihi, Youcef" uniqKey="Saihi Y" first="Youcef" last="Saihi">Youcef Saihi</name>
</country>
<country name="Italie">
<noRegion>
<name sortKey="Maccari, Laura" sort="Maccari, Laura" uniqKey="Maccari L" first="Laura" last="Maccari">Laura Maccari</name>
</noRegion>
<name sortKey="Maccari, Giorgio" sort="Maccari, Giorgio" uniqKey="Maccari G" first="Giorgio" last="Maccari">Giorgio Maccari</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/MaghrebDataLibMedV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000426 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000426 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    MaghrebDataLibMedV2
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:29274684
   |texte=   Identification of novel nt-MGAM inhibitors for potential treatment of type 2 diabetes: Virtual screening, atom based 3D-QSAR model, docking analysis and ADME study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:29274684" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a MaghrebDataLibMedV2 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Wed Jun 30 18:27:05 2021. Site generation: Wed Jun 30 18:34:21 2021